REGN (Regeneron Pharmaceuticals) Technical Analysis

REGN Technical Analysis leverages historical price and volume data to provide real-time indicator values and signals, including RSI, MACD, Bollinger Bands, and volume, to reflect market momentum, volatility ranges, and price-volume dynamics. It also integrates market sentiment metrics such as the VIX volatility index, Advance-Decline ratio (A/D ratio), and Put/Call options ratio for broader market context. Multi-timeframe views span from minute intervals to daily, weekly, and monthly charts, making it easy to track indicator behavior across periods. Key support and resistance levels are displayed alongside current prices, calculated via pivots, Fibonacci retracements, and historical extremes to offer an immediate overview of market structure.
REGN
REGN

Regeneron Pharmaceuticals

$625.99+0.59%
Today's High$631.30
Today's Low$623.05
Today's Open$624.09
Yesterday's Close$622.27

REGN (Regeneron Pharmaceuticals) Technical Analysis Overview

AI CreationAs of June 30, 2026, Regeneron Pharmaceuticals (REGN) is showing mixed technical signals with short-term momentum building against longer-term resistance. The MACD(12,26) displays a Buy signal at −8.26 with momentum strengthening, suggesting early bullish crossover dynamics, while the RSI(14) reading of 47.8582 sits in the neutral zone, indicating limited conviction behind the rally. The moving average system exhibits conflicted alignment, with the daily timeframe showing six Buy signals against eight Sell signals, confirming that intermediate and longer-term resistance remains entrenched above current price action. Overall, **REGN technical analysis** reflects a near-term bullish window constrained by persistent overhead resistance.

Oscillators

Strong Sell
Strong Buy
Neutral
1
Sell
8
Neutral
2
Buy

Summary

Strong Sell
Strong Buy
Neutral
9
Sell
9
Neutral
8
Buy

Moving Averages

Strong Sell
Strong Buy
Sell
8
Sell
1
Neutral
6
Buy

REGN (Regeneron Pharmaceuticals) Live Candlestick Chart

REGN (Regeneron Pharmaceuticals) Multi-Timeframe Technical Rating

Summary1H4H1D1W
Moving Averages (15)779568113
Oscillators (11)NeutralNeutralNeutralNeutral
RSI (14)50.553.848.139.3
MACD (12,26)Golden CrossGolden CrossDeath CrossDeath Cross

REGN (Regeneron Pharmaceuticals) Technical Indicator Interpretation

Based on 1-day closing price series

Oscillators

NameValueOperation
RSI(14)
48.1714Neutral
Stochastic %K (14, 3, 3)
74.8898Neutral
Commodity Channel Index (CCI) (20)
75.8324Neutral
Average Directional Index (ADX) (14)
30.0499Neutral
Awesome Oscillator (AO)
-0.6758Neutral
Momentum Indicator (10)
13.16Buy
MACD Level (12, 26)
-7.4988Buy
Stochastic RSI Fast (3, 3, 14, 14)
84.7778Neutral
Williams Percent Range (%R) (14)
-24.7834Neutral
Bull Bear Power (BBP)
11.0713Sell
Ultimate Oscillator (UO) (7, 14, 28)
45.9219Neutral

Moving Averages

NameValueOperation
EMA (10)
623.2786Buy
SMA (10)
620.811Buy
EMA (20)
625.4763Buy
SMA (20)
618.687Buy
EMA (30)
634.2597Sell
SMA (30)
621.2503Buy
EMA (50)
654.2613Sell
SMA (50)
659.4694Sell
EMA (100)
681.9264Sell
SMA (100)
712.251Sell
EMA (200)
690.5044Sell
SMA (200)
699.5056Sell
Ichimoku Kinko Hyo Base Line (9, 26, 52, 26)
620.0075Neutral
Volume-Weighted Moving Average (VWMA) (20)
617.4559Buy
Hull Moving Average (HMA) (9)
631.4334Sell

REGN (Regeneron Pharmaceuticals) Pivot Points

Based on 1-day timeframe

PriceClassicFibonacciCamarillaWoodieDM
R3717.2267667.9267637.0975703.85-
R2667.9267649.0941632.5783672.335-
R1645.7333637.4593628.0592654.55656.83
Pivot P618.6267618.6267618.6267623.035624.175
S1596.4333599.7941619.0208605.25607.53
S2569.3267588.1593614.5017573.735-
S3520.0267569.3267609.9825555.95-

REGN (Regeneron Pharmaceuticals) Market Sentiment Index

Analyst Rating833.3061
Options Put/Call Ratio+226.53%
Implied Volatility (IV)27.7871

REGN (Regeneron Pharmaceuticals) Deep Technical Analysis

As of June 30, 2026, Regeneron Pharmaceuticals (REGN) is exhibiting a conflicted technical structure between short-term momentum and longer-term trend resistance. The MACD(12,26) holds a Buy signal at −8.26 with momentum strengthening, suggesting early bullish crossover dynamics, while the RSI(14) at 47.8582 occupies the neutral zone between 45 and 55, indicating that buying interest has not yet overcome underlying selling pressure and that the rally lacks strong conviction. Price action shows a daily range from 623.58 (low) to 630.27 (high), with the closing level at 626.07, confirming that the asset remains within a compressed trading band. The Average Directional Index (14) at 30.9861 signals moderate trend persistence, confirming that directional movement is present despite the mixed indicator backdrop. The Commodity Channel Index (20) at 87.3442 sends a Neutral signal, neither confirming nor decisively negating the MACD buy signal, suggesting that oscillator momentum is not cleanly aligned with the short-term bullish pressure. Together, these indicators imply that while upward pressure exists, the broader trend structure remains contested. The moving average system reveals a conflicted alignment that tempers the short-term bullish momentum. EMA10 at 623.053 and SMA20 at 617.6582 both issue Buy signals, confirming short-term upside intent, but EMA20 at 625.6408 and the longer-term averages send mixed-to-bearish signals, indicating that the short-term trend has not yet decisively broken above intermediate resistance. EMA50 at 655.51 and SMA200 at 691.1774 remain well above price, establishing strong medium- and long-term resistance zones that define the broader bearish structure. The daily moving average count of six Buy signals versus eight Sell signals underscores that intermediate and longer-term moving averages are predominantly aligned bearishly, limiting the potential for a sustained rally. The near-term **REGN market analysis** thus hinges on whether price can sustain above the EMA20 and SMA20 confluence zone near 617–626. In terms of key levels, the Fibonacci retracement framework identifies R1 at 697.8666, R2 at 726.3801, and R3 at 772.5333 as resistance targets above the current price of 626.07, while S1 at 605.5601 and S2 at 577.0466 define support below. The recent daily range from a low of 623.58 to a high of 630.27 establishes immediate support near 623.58 and resistance near the 630.27 level. The **REGN price forecast** remains shaped by the tension between short-term momentum strength and the entrenched bearish moving average alignment, with any sustained advance likely to encounter resistance near the EMA20/SMA20 confluence. On the sentiment front, the option Put/Call ratio stands at 35.9, reflecting elevated hedging activity and a bias toward protective put positioning that suggests underlying caution among options traders. The implied volatility at 28.0769 indicates moderately elevated volatility expectations, while the analyst rating at 833.3061 indicates that professional sentiment remains constructive overall. The technical structure and elevated hedging behavior thus suggest that longer-term moving average resistance implies sellers remain positioned above current levels, constraining the **REGN price prediction** despite short-term bullish momentum.

FAQ

What is the current technical rating for REGN?

x
On the 4H timeframe, the aggregate technical rating for REGN is Neutral. This rating is dynamically aggregated from moving averages and momentum oscillators to reflect the prevailing trend direction and price velocity.

Where are the key support and resistance levels for REGN?

x

What are the current RSI and MACD signals for REGN?

x

How often is the REGN technical analysis data updated?

x

Continue Exploring REGN (Regeneron Pharmaceuticals)

Risk Warning:

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Warning.

Disclaimer:

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.